TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Faron Pharmaceuticals Oy
Closing information (x1000 SEK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover | 11,031 | 4,750 | 8,621 |
Financial expenses | 3,454 | 2,841 | 1,389 |
Earnings before taxes | -88,197 | -56,144 | -12,798 |
Total assets | 165,383 | 135,390 | 36,245 |
Current assets | 109,809 | 101,106 | 2,303 |
Current liabilities | 41,807 | 20,070 | 15,815 |
Equity capital | 104,117 | 102,111 | -6,366 |
- share capital | 25,745 | 24,582 | 25,606 |
Employees (average) | 10 | 6 | 5 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency | 63.0% | 75.4% | -17.6% |
Turnover per employee | 1,103 | 792 | 1,724 |
Profit as a percentage of turnover | -799.5% | -1182.0% | -148.5% |
Return on assets (ROA) | -51.2% | -39.4% | -31.5% |
Current ratio | 262.7% | 503.8% | 14.6% |
Return on equity (ROE) | -84.7% | -55.0% | 201.0% |
Change turnover | 6,056 | -3,526 | |
Change turnover % | 122% | -43% | |
Chg. No. of employees | 4 | 1 | |
Chg. No. of employees % | 67% | 20% |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.